A group of cancer researchers in Mexico has lost their third paper over concerns about the integrity of their data.
Neither the new retraction, in the journal Hematology, nor the previous two, cite misconduct as the reason for the removals. However, the statements do refer to lack of reliability of results, “ambiguities and inconsistencies” in the findings and other serious issues.
The first author on each paper is Agustin Avilés, whom the Hematology article listed as being with the National Medical Center in Mexico City.
The Journal of Clinical Investigation has retracted two papers from the lab of one of Stanford University’s most prominent cancer researchers over concerns about the integrity of the data.
The articles, published in 2012 and 2014, described work on ways of priming the immune system to enhance the activity of drugs to fight cancer.
The first author on the two articles was Holbrook “Brook” Kohrt, a superstar young faculty member who died in 2016 of complications of hemophilia. Kohrt was the subject of this 2013 profile in the New York Times, which also wrote an obituary of him.
The journal for a religious medical group is retracting a paper that supported the discredited practice of conversion therapy for homosexuals over concerns about the statistical analyses — or lack thereof — in the research.
The paper, “Effects of therapy on religious men who have unwanted same-sex attraction,” was published last year in The Linacre Quarterly, the official journal of the Catholic Medical Association. (According to its website: “LQR explores issues at the interface of medicine and religion, focusing on bioethics and also exploring medical topics which have an ethical dimension.)
So, what were those effects? Pretty darn good, according to the article. Per the abstract:
Saying that a paper has “fatal and disqualifying errors,” CrossFit is demanding the retraction of a recently published article that claimed those participating in CrossFit “are more likely to be injured and to seek medical treatment compared with participants in traditional weightlifting.”
We often praise authors for doing the right thing by retracting with transparency. Here’s a journal that deserves recognition for its handling of a case of duplicate publication.
Acta Dermatovenerologica Alpina, Pannonica et Adriatica (ADAPA), a European derm publication, has retracted a 2018 article in smack-down fashion, calling out a co-author for deceit. The paper was a case study titled “Inflamed bilateral linear atrophoderma of Moulin in an adult woman: a case report.” According to ADAPA, a reader noticed that a virtually identical article — with the same title — had appeared in a Turkish dermatology publication in late 2017.
Carlo Croce, a professor at The Ohio State University in Columbus who has faced multiple investigations into misconduct allegations, has been denied a temporary restraining order that he sought in order to be reinstated as chair of his department.
Croce was forced to step down from the post last year. Magistrate Jennifer D. Hunt, of the Franklin County civil court, wrote in a January 23 decision that
third parties and the public interest will be harmed if a temporary restraining order is granted and Dr. Croce is reinstated as Chair.
A group of rheumatology researchers in Egypt that lost a paper in 2016 for a variety of problems has lost two more.
The authors common to the two papers, Anna Abou-Raya and Suzan Abou-Raya, are based at the University of Alexandria, which did not find evidence of scientific misconduct, according to one of the retraction notices. The journal that published the two papers, The Journal of Rheumatology, however, found several other issues that led them to retract the papers.
Carlo Croce, the embattled cancer researcher at The Ohio State University (OSU), is suing the institution to reclaim the department chair he lost late last year for reasons that he says are unclear.
In a filing with the Franklin County civil court, Croce and his attorneys, from the Columbus firm of James E. Arnold and Associates, argue that the university failed to follow its own rules for demoting faculty members last year when it stripped Croce of his position of chair of the Department of Cancer Genetics and Biology. Croce had held the post for more than three consecutive four-year terms, starting in October 2004.
Two months after Harvard and the Brigham and Women’s Hospital said they were requesting the retraction of more than 30 papers from a former cardiac stem cell lab there, two American Heart Association journals have retracted more than a dozen papers from the lab.